130 related articles for article (PubMed ID: 27460599)
21. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
22. Comparative Morphological Analysis of MCF10A and MCF7 Cells Using Holographic Time-lapse Microscopy.
McLaughlin AJ; Kaniski AJ; Matti DI; Xhabija B
Anticancer Res; 2023 Sep; 43(9):3891-3896. PubMed ID: 37648303
[TBL] [Abstract][Full Text] [Related]
23. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
[TBL] [Abstract][Full Text] [Related]
24. Rapid and sensitive phenotypic marker detection on breast cancer cells using surface-enhanced Raman scattering (SERS) imaging.
Lee S; Chon H; Lee J; Ko J; Chung BH; Lim DW; Choo J
Biosens Bioelectron; 2014 Jan; 51():238-43. PubMed ID: 23973735
[TBL] [Abstract][Full Text] [Related]
25. New look inside human breast ducts with Raman imaging. Raman candidates as diagnostic markers for breast cancer prognosis: Mammaglobin, palmitic acid and sphingomyelin.
Abramczyk H; Brozek-Pluska B
Anal Chim Acta; 2016 Feb; 909():91-100. PubMed ID: 26851089
[TBL] [Abstract][Full Text] [Related]
26. Nanoscale Optical Microscopy and Spectroscopy Using Near-Field Probes.
Hermann RJ; Gordon MJ
Annu Rev Chem Biomol Eng; 2018 Jun; 9():365-387. PubMed ID: 29596000
[TBL] [Abstract][Full Text] [Related]
27. Nanoscale residual stress-field mappingaround nanoindents in SiCby IR s-SNOM and confocal Raman microscopy.
Gigler AM; Huber AJ; Bauer M; Ziegler A; Hillenbrand R; Stark RW
Opt Express; 2009 Dec; 17(25):22351-7. PubMed ID: 20052158
[TBL] [Abstract][Full Text] [Related]
28. Differential Ratios of Omega Fatty Acids (AA/EPA+DHA) Modulate Growth, Lipid Peroxidation and Expression of Tumor Regulatory MARBPs in Breast Cancer Cell Lines MCF7 and MDA-MB-231.
Mansara PP; Deshpande RA; Vaidya MM; Kaul-Ghanekar R
PLoS One; 2015; 10(9):e0136542. PubMed ID: 26325577
[TBL] [Abstract][Full Text] [Related]
29. MCF10A and MDA-MB-231 human breast basal epithelial cell co-culture in silicon micro-arrays.
Nikkhah M; Strobl JS; Schmelz EM; Roberts PC; Zhou H; Agah M
Biomaterials; 2011 Oct; 32(30):7625-32. PubMed ID: 21764441
[TBL] [Abstract][Full Text] [Related]
30. Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy.
Matthews Q; Jirasek A; Lum JJ; Brolo AG
Phys Med Biol; 2011 Nov; 56(21):6839-55. PubMed ID: 21971286
[TBL] [Abstract][Full Text] [Related]
31. Coarse Raman and optical diffraction tomographic imaging enable label-free phenotyping of isogenic breast cancer cells of varying metastatic potential.
Paidi SK; Shah V; Raj P; Glunde K; Pandey R; Barman I
Biosens Bioelectron; 2021 Mar; 175():112863. PubMed ID: 33272866
[TBL] [Abstract][Full Text] [Related]
32. Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.
Marro M; Nieva C; Sanz-Pamplona R; Sierra A
Biochim Biophys Acta; 2014 Sep; 1843(9):1785-95. PubMed ID: 24747691
[TBL] [Abstract][Full Text] [Related]
33. Cellular discrimination using in vitro Raman micro spectroscopy: the role of the nucleolus.
Farhane Z; Bonnier F; Casey A; Maguire A; O'Neill L; Byrne HJ
Analyst; 2015 Sep; 140(17):5908-19. PubMed ID: 26207998
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.
Dagdemir A; Judes G; Lebert A; Echegut M; Karsli-Ceppioglu S; Rifaï K; Daures M; Ngollo M; Dubois L; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Cancer Genomics Proteomics; 2016; 13(4):291-303. PubMed ID: 27365379
[TBL] [Abstract][Full Text] [Related]
35. Label-Free Raman Imaging to Monitor Breast Tumor Signatures.
Manciu FS; Ciubuc JD; Parra K; Manciu M; Bennet KE; Valenzuela P; Sundin EM; Durrer WG; Reza L; Francia G
Technol Cancer Res Treat; 2017 Aug; 16(4):461-469. PubMed ID: 27381847
[TBL] [Abstract][Full Text] [Related]
36. Characterization of inflammatory breast cancer: a vibrational microspectroscopy and imaging approach at the cellular and tissue level.
Mohamed HT; Untereiner V; Proult I; Ibrahim SA; Götte M; El-Shinawi M; Mohamed MM; Sockalingum GD; Brézillon S
Analyst; 2018 Dec; 143(24):6103-6112. PubMed ID: 30468236
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic mechanisms regulate the prostaglandin E receptor 2 in breast cancer.
To SQ; Takagi K; Miki Y; Suzuki K; Abe E; Yang Y; Sasano H; Simpson ER; Knower KC; Clyne CD
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):331-8. PubMed ID: 22929011
[TBL] [Abstract][Full Text] [Related]
38. Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors.
Lapierre M; Linares A; Dalvai M; Duraffourd C; Bonnet S; Boulahtouf A; Rodriguez C; Jalaguier S; Assou S; Orsetti B; Balaguer P; Maudelonde T; Blache P; Bystricky K; Boulle N; Cavaillès V
Oncotarget; 2016 Apr; 7(15):19693-708. PubMed ID: 26930713
[TBL] [Abstract][Full Text] [Related]
39. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
40. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
